Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.5150
-0.0349 (-6.35%)
At close: Apr 1, 2025, 4:00 PM
0.5399
+0.0249 (4.83%)
After-hours: Apr 1, 2025, 5:06 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $7.43 million as of April 1, 2025. Its market cap has decreased by -54.41% in one year.
Market Cap
7.43M
Enterprise Value
2.23M
1-Year Change
-54.41%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since August 4, 2015, Indaptus Therapeutics's market cap has decreased from $60.70M to $7.43M, a decrease of -87.76%. That is a compound annual growth rate of -19.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 7.90M | -8.14% |
| Dec 31, 2024 | 8.60M | -41.89% |
| Dec 29, 2023 | 14.80M | 23.33% |
| Dec 30, 2022 | 12.00M | -74.30% |
| Dec 31, 2021 | 46.70M | 243.38% |
| Dec 31, 2020 | 13.60M | -22.29% |
| Dec 31, 2019 | 17.50M | -91.10% |
| Dec 31, 2018 | 196.60M | 233.22% |
| Dec 29, 2017 | 59.00M | -9.65% |
| Dec 30, 2016 | 65.30M | 20.48% |
| Dec 31, 2015 | 54.20M | -10.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |